Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Harvard Business School
McKesson
Mallinckrodt
Julphar
Federal Trade Commission
Fish and Richardson
Chinese Patent Office
AstraZeneca
Baxter

Generated: December 11, 2017

DrugPatentWatch Database Preview

MEXILETINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Mexiletine Hydrochloride patents expire, and when can generic versions of Mexiletine Hydrochloride launch?

Mexiletine Hydrochloride is a drug marketed by Idt Australia Ltd, Teva, and Watson Labs. and is included in four NDAs.

The generic ingredient in MEXILETINE HYDROCHLORIDE is mexiletine hydrochloride. There are five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the mexiletine hydrochloride profile page.
Drug patent expirations by year for MEXILETINE HYDROCHLORIDE

Pharmacology for MEXILETINE HYDROCHLORIDE

Drug ClassAntiarrhythmic

Medical Subject Heading (MeSH) Categories for MEXILETINE HYDROCHLORIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Idt Australia LtdMEXILETINE HYDROCHLORIDEmexiletine hydrochlorideCAPSULE;ORAL074450-001May 16, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsMEXILETINE HYDROCHLORIDEmexiletine hydrochlorideCAPSULE;ORAL074711-001Feb 26, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaMEXILETINE HYDROCHLORIDEmexiletine hydrochlorideCAPSULE;ORAL074377-001May 16, 1995RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsMEXILETINE HYDROCHLORIDEmexiletine hydrochlorideCAPSULE;ORAL074865-003Apr 13, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsMEXILETINE HYDROCHLORIDEmexiletine hydrochlorideCAPSULE;ORAL074865-001Apr 13, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Idt Australia LtdMEXILETINE HYDROCHLORIDEmexiletine hydrochlorideCAPSULE;ORAL074450-002May 16, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Idt Australia LtdMEXILETINE HYDROCHLORIDEmexiletine hydrochlorideCAPSULE;ORAL074450-003May 16, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaMEXILETINE HYDROCHLORIDEmexiletine hydrochlorideCAPSULE;ORAL074377-003May 16, 1995RXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
TevaMEXILETINE HYDROCHLORIDEmexiletine hydrochlorideCAPSULE;ORAL074377-002May 16, 1995RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsMEXILETINE HYDROCHLORIDEmexiletine hydrochlorideCAPSULE;ORAL074865-002Apr 13, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Deloitte
Boehringer Ingelheim
Julphar
McKinsey
Farmers Insurance
Healthtrust
AstraZeneca
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot